Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease
- PMID: 32529770
- DOI: 10.1111/apt.15775
Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease
Comment in
-
Letter: off-label use of hyperbaric oxygen therapy in inflammatory bowel disease-Authors' reply.Aliment Pharmacol Ther. 2020 Jul;52(1):216-217. doi: 10.1111/apt.15806. Aliment Pharmacol Ther. 2020. PMID: 32529768 No abstract available.
Comment on
-
Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis.Aliment Pharmacol Ther. 2019 May;49(10):1293-1300. doi: 10.1111/apt.15229. Epub 2019 Mar 25. Aliment Pharmacol Ther. 2019. PMID: 30908719 Free PMC article.
References
REFERENCES
-
- Simsek M, Lissenberg-Witte BI, van Riswijk MLM, et al. Off-label prescriptions of drugs used for the treatment of Crohn's disease or ulcerative colitis. Aliment Pharmacol Ther. 2019;49:1293-1300.
-
- Dulai PS, Gleeson MW, Taylor D, et al. Systematic review: the safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease. Aliment Pharmacol Ther. 2014;39:1266-1275.
-
- Dulai PS, Buckey JC, Raffals LE, et al. Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial. Am J Gastroenterol. 2018;113:1516-1523.
-
- Fosen KM, Thom SR. Hyperbaric oxygen, vasculogenic stem cells, and wound healing. Antioxid Redox Signal. 2014;21:1634-1647.
-
- Camporesi EM, Bosco G. Mechanisms of action of hyperbaric oxygen therapy. Undersea Hyperb Med. 2014;41:247-252.
Publication types
MeSH terms
LinkOut - more resources
Medical